Although reports of vision problems with weight loss drugs are still rare, researchers say there is cause for concern because of how widespread the medications are becoming. A 2024 study found that 12 ...
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...
Cutting government waste is a good aim, but we need a bold new vision and priorities to tackle the drug crisis.
Genova 5-ounce cans involved in the recall were sold at Harris Teeter, Publix, H-E-B, Kroger, Safeway, Walmart and ...
USA News Group News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, Feb. 11, 2025 /PRNewswire/ -- USA News Group News Commentary - Weeks after the monumental ...
Beyond Stargate's big players, a growing number of innovators have been revolutionizing healthcare by making recent ...
The FDA has made some modest efforts, but it needs an internal organization that understands and would be an aggressive ...
Cutting-Edge Cardiac Research: Novoheart’s CTScreen™ system has been installed at UMC Utrecht, equipping Regenerative Medicine Center with advanced high-throughput tools to accelerate human cardiac ...
State-of-the-art transactional repository (rTH): the fully GS1-compliant central hub will securely manage all supply chain ...
A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...
Nearly every disease has an inflammatory component, but blood tests can't pinpoint inflammation in specific organs or tissues in the human body.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback